Daily non-political popular news in brief.

Intravenous nanoparticle gene therapy shows activity in stage IV lung cancer

A cancer-suppressing gene has been successfully delivered into the tumors of stage four lung cancer patients via an intravenously administered lipid nanoparticle in a phase I clinical trial at the University of Texas M. D. Anderson Cancer Center. The gene, FUS1, also was found to be active in the metastatic nonsmall cell lung cancer tumors.

Read more »

Keywords: intravenous, nanoparticle, gene, therapy, shows, activity, stage, lung, cancer, intravenou, show

« Previous | Next »

Similar news on "Intravenous nanoparticle gene therapy shows activity in stage IV lung cancer":

1. Gene's activity points to more lethal subtype of AML
   07-09-2007 · EurekAlert!
   A new study shows that the activity of a particular gene can identify people who have a more lethal form of acute myeloid leukemia, singling out those patients who should receive more intense therapy. The gene, called ERG (for ETS-related gene), has also been linked to chronic leukemia and to breast and prostate cancer.
   Similar news · Read more »
   
2. VEGF Trap shows activity in patients with advanced ovarian cancer
   06-02-2007 · EurekAlert!
   Preliminary results of a randomized, international Phase II trial of VEGF Trap (aflibercept) show activity in patients with recurrent epithelial ovarian cancer (EOC) who had received three or four prior chemotherapy regimens and had become resistant to platinum-based chemotherapy agents. The findings, which are being presented today at the American Society of Clinical Oncology’s annual meeting, may indicate a role for this targeted therapy in women with ovarian cancer who have exhausted all other options.
   Similar news · Read more »
   
3. Breast cancer susceptibility gene predicts outcome and response to treatment in lung cancer
   09-25-2007 · EurekAlert!
   Researchers have found that the breast cancer susceptibility gene, BRCA1, plays a significant role in nonsmall cell lung cancer. They told the European Cancer Conference in Barcelona that not only can it be used to predict outcome for patients with NSCLC, but it may also prove to be a valuable tool in choosing the best therapy for them.
   Similar news · Read more »
   
4. Antibiotic Inhibits Cancer Gene Activity
   10-02-2006 · ScienceDaily
   A little-known antibiotic shows early promise as an anti-cancer agent, inhibiting a gene found at higher-than-normal levels in most human tumors, according to researchers at the University of Illinois at Chicago College of Medicine.
   Similar news · Read more »
   
5. Tumor Suicide: Gene therapy makes cancer cells self-destruct
   07-14-2007 · Science News Online
   Microscopic bubbles of fat that deliver a suicide gene to tumor cells show success in treating pancreatic cancer in mice.
   Similar news · Read more »
   
6. Study reveals differences in cancer stage presentation between rural and urban patients
   11-09-2007 · EurekAlert!
   New research published in the November issue of the Journal of the American College of Surgeons shows that urban colorectal and lung cancer patients present at later stages of disease than rural patients do. This finding is contrary to the common assumption that rural patients with cancer present at a later stage of disease in comparison with urban patients.
   Similar news · Read more »
   
7. Phase I pharmacokinetic study of ECO-4601, a novel bifunctional targeting agent
   10-24-2007 · EurekAlert!
   A first-in-class, targeted investigational therapy specifically designed to inhibit a single protein that functions only during cell division shows potent activity in a broad range of cancer cell lines, say researchers presenting at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.
   Similar news · Read more »
   
8. Molecule blocks gene, sheds light on liver cancer
   08-01-2007 · EurekAlert!
   New research shows how a particular small molecule blocks the activity of a cancer-suppressing gene, allowing liver cancer cells to grow and spread. This molecule is a microRNA, a recently discovered class of tiny molecules used by cells to help control the kinds and amounts of proteins they make. More than 250 different microRNAs have been discovered, and several have been linked to cancer.
   Similar news · Read more »
   
9. One Wwox isn't enough (to protect against cancer)
   03-15-2007 · EurekAlert!
   A new study shows that the loss of even one of the two copies of a particular tumor-suppressor gene greatly increases the risk that lung cancer will develop in experimental animals. The study examined the Wwox gene, a suspected tumor-suppressor gene, and showed that even when mice have one working copy of the gene, they nonetheless develop five times more lung tumors than do mice with both copies of the gene.
   Similar news · Read more »
   
10. Targeted, oral agent Enzastaurin shows favorable results
    06-02-2007 · EurekAlert!
    Enzastaurin, an investigational targeted, oral agent under development by Eli Lilly and Company, showed encouraging results in treating patients with late-stage non-small cell lung cancer (NSCLC), according to data presented today at the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO).
    Similar news · Read more »